kx- 826
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
2
Phase 4
0
Earliest trial started Sep 28, 2020 (NCT05940506)
Timeline
Indications
Studied for
Mechanism of action
- Androgen ReceptorANTAGONIST
androgen receptor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06622824 | Phase 2/Phase 3 (Phase 3) | Oct 15, 2024 | Government of China, Suzhou Kintor Pharmaceutical Inc, |
| NCT05218642 | Phase 2 | Jan 31, 2022 | Suzhou Kintor Pharmaceutical Inc, |
| NCT06126965 | Phase 3 | Dec 29, 2021 | Fudan University, Government of China, Peking University, Suzhou Kintor Pharmaceutical Inc, |
| NCT06409650 | Phase 2 | Nov 9, 2021 | Government of China |
| NCT05940506 | Phase 2 | Sep 28, 2020 | Fudan University, Peking University, Suzhou Kintor Pharmaceutical Inc, |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Suzhou Kintor Pharmaceutical Inc, | For profit | 4 | 4 | 2 | 2020 |
| Government of China | Government | 3 | 1 | 2 | 2021 |
| Fudan University | Academic/Hospital | 2 | 0 | 2 | 2020 |
| Peking University | Academic/Hospital | 2 | 0 | 2 | 2020 |
4 organizations
Page 1 / 1